Alnylam Pharmaceuticals, Inc. (ALNY)
236.56
-2.44
(-1.02%)
USD |
NASDAQ |
Aug 27, 16:00
220.17
-16.39
(-6.93%)
After-Hours: 07:23
Alnylam Pharmaceuticals 30-Day Average Daily Volume : 2.034M for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.034M |
| August 26, 2026 | 2.039M |
| August 25, 2026 | 2.044M |
| August 24, 2026 | 2.028M |
| August 21, 2026 | 2.047M |
| August 20, 2026 | 2.068M |
| August 19, 2026 | 2.206M |
| August 18, 2026 | 2.174M |
| August 17, 2026 | 2.153M |
| August 14, 2026 | 2.131M |
| August 13, 2026 | 2.117M |
| August 12, 2026 | 2.104M |
| August 11, 2026 | 2.097M |
| August 10, 2026 | 2.095M |
| August 07, 2026 | 2.098M |
| August 06, 2026 | 2.078M |
| August 05, 2026 | 2.045M |
| August 04, 2026 | 1.990M |
| August 03, 2026 | 1.934M |
| July 31, 2026 | 1.894M |
| July 30, 2026 | 1.789M |
| July 29, 2026 | 1.502M |
| July 28, 2026 | 1.495M |
| July 27, 2026 | 1.495M |
| July 24, 2026 | 1.483M |
| Date | Value |
|---|---|
| July 23, 2026 | 1.476M |
| July 22, 2026 | 1.480M |
| July 21, 2026 | 1.498M |
| July 20, 2026 | 1.499M |
| July 17, 2026 | 1.489M |
| July 16, 2026 | 1.476M |
| July 15, 2026 | 1.463M |
| July 14, 2026 | 1.460M |
| July 13, 2026 | 1.500M |
| July 10, 2026 | 1.444M |
| July 09, 2026 | 1.381M |
| July 08, 2026 | 1.207M |
| July 07, 2026 | 1.199M |
| July 06, 2026 | 1.188M |
| July 02, 2026 | 1.185M |
| July 01, 2026 | 1.175M |
| June 30, 2026 | 1.168M |
| June 29, 2026 | 1.159M |
| June 26, 2026 | 1.143M |
| June 25, 2026 | 1.126M |
| June 24, 2026 | 1.116M |
| June 23, 2026 | 1.116M |
| June 22, 2026 | 1.110M |
| June 18, 2026 | 1.101M |
| June 17, 2026 | 1.061M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.702M |
| Regeneron Pharmaceuticals, Inc. | 778928.9 |
| Vertex Pharmaceuticals, Inc. | 1.258M |
| BridgeBio Pharma, Inc. | 2.037M |
| Pfizer Inc. | 38.26M |